Increasing number of individuals diagnosed with infertility accompanied with rising consumer awareness for infertility treatments in both developing as well as developed nations is positively affecting the drugs infertility market size. Moreover, economics growth in developing countries will further support in enhancing industry share.
As the drug infertility industry consists of few dominating players, the majority of them are engaged in providing enhanced products and improve their market presence. Amending government regulations relevant to operation of chorionic gonadotropin will improve the drugs infertility industry size over the study period.
Global drugs infertility market is segregated on the basis of product as, Assisted Reproductive Technology, Infertility Drug Services, and Fertility Surgeries. Based on application, the global drugs infertility market is segmented as Male and Female.
Global drugs infertility market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The drugs infertility market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
CARE Fertility Group Limited, NMC Health Plc, Reproductive Medicine Associates of New Jersey, Bayer, Virtus Health Limited, Merck, Ferring Holding, Sanofi, Fairview Health Services and Abbott Laboratories are among the major players in the global drugs infertility market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drugs Infertility Market has been segmented as follows:
Drugs Infertility Market, By Product
Drugs Infertility Market, By Application
Drugs Infertility Market, By Region
The report covers:
Report scope:
Global drugs infertility market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global drugs infertility market share. Major industry players with significant revenue share include CARE Fertility Group Limited, NMC Health Plc, Reproductive Medicine Associates of New Jersey, Bayer, Virtus Health Limited, Merck, Ferring Holding, Sanofi, Fairview Health Services and Abbott Laboratories.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Ageing and infertility
4.2.2. Increasing prevalence of obesity
4.2.3. Cultural shifts
4.3. Restraints
4.3.1. Population control and family planning
4.3.2. High treatment cost
4.4. Opportunities
4.4.1. Rising average age of first birth
4.4.2. Merger and acquisitions among industry players
4.5. Challenges
4.5.1. Stringent regulation
5. Drugs Infertility Market, By Product
5.1. Key Points
5.2. Assisted Reproductive Technology
5.3. Infertility Drug Services
5.4. Fertility Surgeries
6. Drugs Infertility Market, By Application
6.1. Key Points
6.2. Male
6.3. Female
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. CARE Fertility Group Limited
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. NMC Health Plc
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. Reproductive Medicine Associates of New Jersey
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. Bayer
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Virtus Health Limited
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Merck
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. Ferring Holding
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Sanofi
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Fairview Health Services
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
8.10. Abbott Laboratories
8.10.1. Company Overview
8.10.2. Product/Service Landscape
8.10.3. Financial Overview
8.10.4. Recent Developments
The Drugs Infertility Market has been segmented as follows:
Drugs Infertility Market, By Product
Drugs Infertility Market, By Application
Drugs Infertility Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
